Rocket Lab’s $266 Million Air Force Deal Can’t Escape the Gravity of a Sector-Wide Rotation
Published on 07/25/2026 at 12:21 | Redaktion boerse-global.de
The numbers tell a brutal story. Rocket Lab’s stock closed at €56.40 on Friday, shedding 8.29% in a single session and nearly a quarter of its value over the past 30 days. Yet the company spent that same month racking up achievements that would make any defense contractor proud — a $266 million firm-fixed-price contract with the US Air Force, a slot in the Space Force’s NSSL Phase 3 Lane 1 program, and two new NASA mission awards. The disconnect between operational momentum and market sentiment has rarely been starker.
A Defense Contractor in All But Name
The Air Force deal covers twelve suborbital Electron launches from Alaska’s Pacific Spaceport Complex, running through December 2028. It builds on a $190 million contract awarded earlier this year. Stifel analysts read the win as validation that Rocket Lab’s HASTE hypersonic test platform has real operational relevance, just as Washington accelerates its hypersonic weapons push.
That was followed by admission into the Space Force’s NSSL Phase 3 Lane 1 program, placing Rocket Lab among seven approved providers for national security launches tethered to a $17 billion funding ceiling. NASA added two more mission orders — PolSIR and TSIS-2 — collectively worth under $30 million. Modest in dollar terms, but another notch in a rapidly expanding roster of government clients.
The Iridium Wildcard
The strategic pivot that truly reshapes Rocket Lab’s trajectory is the planned $8 billion acquisition of Iridium Communications. Announced in late June, the deal prices Iridium shares at $54 apiece, payable in a mix of cash and stock. Both companies frame it as a merger of Rocket Lab’s launch and spacecraft manufacturing with Iridium’s low-earth-orbit satellite network — creating a vertically integrated space powerhouse that designs, builds, launches, and operates its own constellations.
Should investors sell immediately? Or is it worth buying Rocket Lab?
The transaction still requires shareholder and regulatory approval, with closing expected by mid-2026. For long-term bulls, this is the kind of deal that can redefine a company’s earnings profile years down the road. In the near term, however, it adds integration risk that nervous investors are already pricing in.
Neutron: The Unproven Engine
Behind the valuation compression lies a more fundamental anxiety: Neutron, Rocket Lab’s next-generation rocket, remains the linchpin of the long-term profitability thesis — and it hasn’t flown yet. CEO Peter Beck has pointed to the test stands as the critical vantage point, signaling just how closely the market is watching Neutron’s timeline as a sentiment driver. A rocket program under that level of scrutiny is exactly the kind of execution risk that punishes high-multiple growth stocks disproportionately when sentiment turns — and it has turned.
Piper Sandler’s recent coverage initiation underscored the shift. Analyst Alexander Potter assigned Rocket Lab a Neutral rating while favoring competitor AST SpaceMobile on valuation grounds. Both stocks sold off on the news, but the damage was part of a broader sector rotation rather than a company-specific indictment.
Technical Pain, Structural Opportunity
The stock now trades 57.85% below its 52-week high of €133.80 set on May 27. It sits beneath all major moving averages, including the 200-day line at €67.36 — a textbook bearish configuration. The 14-day RSI of 30.8 signals oversold territory, while annualized 30-day volatility of 88.21% underscores the turbulence. Historically, such conditions can trigger sharp relief rallies, but for a stock this volatile, they can also persist for weeks without a clear catalyst.
Zooming out offers a different perspective: even after July’s carnage, Rocket Lab shares remain up 37.56% over twelve months. That tension — a brutal month inside a strong year — defines the current moment. The consensus price target from 17 analysts stands at €114.33, implying roughly 78% upside from current levels. But those models likely haven’t fully absorbed the latest selling wave, and they assume Neutron development stays on schedule.
Rocket Lab at a turning point? This analysis reveals what investors need to know now.
The August 10 Earnings Test
The next real inflection point comes after the bell on August 10, 2026, when Rocket Lab reports quarterly results. The numbers will need to show that backlog growth and contract momentum are accelerating fast enough to offset the capital intensity of two simultaneous undertakings: ramping up Neutron and digesting a billion-dollar acquisition.
What’s happening to Rocket Lab’s stock looks less like a company-specific failure than a sector-wide repricing of speculative space equities. Peers have suffered similar drawdowns as new, well-funded competitors compete for investor attention. A sector rotation is different from operational underperformance — but it hurts shareholders just the same. For patient, risk-tolerant investors, the setup may eventually prove compelling. For those seeking near-term stability, this remains a news-driven, high-volatility trade.
Ad
Rocket Lab Stock: New Analysis - 25 July
Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
